Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: A useful tool to effect changes in management

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 655-662

  Iqbal, M ^a   Creger, R J ^a   Fox, R M ^a   Cooper, B W ^a   Jacobs, G ^b   Stellato, T A ^b   Lazarus, H M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Graft versus host disease; Hepatic dysfunction; Laparoscopy; Neutropenia; Thrombocytopenia; Transplantation

Indexed keywords

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANDIDIASIS; CAUTERIZATION; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; FATTY LIVER; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOMA; HEMATOLOGIC DISEASE; HEMOSIDEROSIS; HEPATITIS; HUMAN; HUMAN TISSUE; INTOXICATION; LAPAROSCOPY; LEUKOCYTE; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER TUMOR; LIVER VENOOCCLUSIVE DISEASE; MALE; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT PLANNING; VIRUS INFECTION;

ADULT; ANEMIA, APLASTIC; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; CANDIDIASIS; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMORRHAGE; HEPATIC VENO-OCCLUSIVE DISEASE; HEPATITIS; HUMANS; IMMUNOSUPPRESSION; LAPAROSCOPY; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; THROMBOCYTOPENIA;

EID: 0030008003     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. McDonald GB, Sharma P, Matthews DE et al. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122.
2. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort of 355 patients. Ann Intern Med 1993; 118: 255-267.
3. Jones RJ, Lee KS, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783.
4. Ganem G, Saint-Marc Girardin MF, Kuentz M et al. Veno-occlusive disease of the liver after allogeneic bone marrow tranplantation in man. Int J Radiat Oncol Biol Phys 1988; 14: 879-884.
5. Nevill TJ, Bamett MJ, Klingemann HG et al. Regimen-related toxicity of a busulfan-cycophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation. J Clin Oncol 1991; 9: 1224-1232.
6. Shulman HM, McDonald GB. Liver disease after marrow transplantation. In: Sale GE, Shulman HM (eds). The Pathology of Bone Marrow Transplantation Masson Publishing: New York, 1984, pp 104-135.
7. Suzuki A, Takahashi T et al. Liver damage in patients with colony stimulating factor-producing tumors. Am J Med 1993; 94: 125-132.
8. Ayash LJ, Hunt M, Antman K et al. Hepatic veno-occlusive disease in autologous bone marrow transplantation of solid tumors and lymphomas. J Clin Oncol 1990; 8: 1699-1706.
9. Snover DC, Weisdorf S, Bloomer J et al. Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 1989; 9: 443-448.
10. Babb RR, Jackman RJ. Needle biopsy of the liver: a critique of four currently available methods. West J Med 1989; 150: 39-42.
11. McAfee JH, Keefe EB, Lee RG, Rosch J. Transjugular liver biopsy. Hepatology 1992: 15: 726-732.
12. Leskinen R, Volin L, Taskinen E et al. Monitoring of bone marrow transplant recipient liver by fine needle aspiration biopsy. Transplantation 1989; 48: 969-974.
13. Rio B, Andreu G, Nicod A et al. Thrombocytopenia in veno-occlusive disease after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773-1776.
14. . 14 Sharma P, McDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol 1982; 4: 451-453.
15. Sloane JP, Farthing MJ, Powles RL. Histopathological changes in the liver after allogeneic bone marrow transplantation. J Clin Pathol 1980: 33: 344-350.
16. Soper NJ, Brunt LM, Kerbl K. Laparoscopic general surgery. New Engl J Med 1994; 330: 409-419.
17. Lazarus HM, Fox RM, Creger RJ et al. Hepatic dysfunction in patients with carcinoma who are severely thrombocytopenic and immunosuppressed. J Am Coll Surg 1994; 179: 433-439.
18. Lawrence JB, Yomtovian RA, Dillman C et al. Reliability of automated platelet counts: comparison with manual method and utility for prediction of clinical bleeding. Am J Hematol 1995; 48: 244-250.
19. Hasson HM. Open laparoscopy: a report of 150 cases. J Reprod Med 1974; 12: 234-238.
20. Frickhofen N, Kaltwasser JP, Schrezenmeier H et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. New Engl J Med 1991; 324: 1297-1304.
21. Vogler WR, Velez-Garcia E, Omura G, Raney M. A phase three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myeloid leukemia. Semin Oncol 1989; 16: 21-24.
22. Cassileth PA, Andersen J, Lazarus HM et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314-319.
23. Lazarus HM, Crilley P, Ciobanu N et al. High-dose carraustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. J Clin Oncol 1992; 10: 1682-3689.
24. Storb R, Deeg HJ, Farewell V et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119-125.
25. Copelan EA, Tutschka PJ. Marrow transplantation following busulfan and cyclophosphamide for multiple myeloma. Bone Marrow Transplant 1988; 3: 363-365.
26. Fay J, Wolff S, Herzig R et al. Treatment of non-Hodgkin's lyphoma with intensive VP-16, cyclophosphamide, total body irradiation and autologous marrow transplantation. Proc Am Soc Clin Oncol 1991; 10: 70 (abstr. 1006).
27. Fields KK, Elfenbein GJ, Lazarus HM et al. Maximum tolerated doses of ifosfamide, carboplatin, and etoposide given over six days followed by autologous stem cell rescue: toxicity profile. J Clin Oncol 1995; 13: 323-332.
28. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
29. Antman K, Ayash L, Elias A et al. A phase II study of high dose cyciophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy. J Clin Oncol 1992; 10: 102-110.
30. Hoelzer D, Thiel E, Loeffler H et al. Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 1984; 64: 38-47.
31. Ho AD, Lipp T, Ehninger G et al. Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia - an active well tolerated regimen. J Clin Oncol 1988; 6: 213-217.
32. Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New Engl J Med 1993; 328: 1002-1006.
33. Lazarus HM, Winton EF, Williams SF et al. A phase I multi-center trial of interleukin-6 therapy after autologous bone marrow transplantation in advanced breast cancer. Bone Marrow Transplant 1995; 15: 935-942.
34. Storb R, Deeg HJ, Pepe M et al. Methotrexate and cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long term follow-up of a controlled trial. Blood 1989; 73: 1729-1734.
35. Tutschka PJ, Copelan EA. Prevention of severe GVHD employing cyclosporine in HLA-matched marrow transplant for leukemia. In: Baum SJ, Santos GW, Takaka F (eds). Experimental Hematology Today. Springer-Verlag: New York, 1987. pp 145-149.
36. Weber J, Yang JC, Topalian SL et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 1993; 11: 499-506.
37. Baglin TP, Harper P, Marcus RE. Veno-occiusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rTPA). Bone Marrow Transplant 1990; 5: 439-441.
38. Ibrahim A, Pico JL, Maraninch D et al. Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1. Bone Marrow Transplant 1991; 7 (Suppl. 2): 53 (abstr.).
39. Murray JA, Labreque DR, Gingrich RD et al. Successful treatment of hepatic veno-occlusive disease in a bone marrow transplant patient with side-to-side portacaval shunt. Gastroenterology 1987; 92: 1073-1077.
40. Rapoport A. Doyle H, Starzl T et al. Orthotopic liver transplantation for life threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant. Bone Marrow Transplant 1991; 8: 421-424.
41. Sable C, Donowitz G. Infections in bone marrow transplant recipients. Clin Infect Dis 1994; 18: 273-284.
42. Kriegshauer JS, Charboneau JW, Letendre L. Hepatic veno-occlusive disease after bone marrow transplantation: diagnosis with duplex sonography. Am J Radiol 1990; 150: 289-290.
43. Brown BP, Aub-Yousef M, Farner R et al. Doppier sonography: a noninvasive method for evaluation of hepatic veno-occlusive disease. Am J Radiol 1990; 154: 721-724.
44. Bolstein MD, Paltiel OB, Thibault A, Rybka WB. A comparison of clinical criteria for diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 439-443.
45. Shulman HM, Fisher LB, Schoch HG et al. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171-1180.
46. Shulman HM, McDonald GB, Matthews D et al. An analysis of hepatic veno-occlusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenierology 1980; 79: 1178-1191.
47. Cohen M, Kader H, Lambers D et al. Complications of percutaneous liver biopsy in children. Gastroenterology 1992; 102: 629-632.
48. Carreras E, Granena A, Navasa M et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993; 11: 21-26.
49. Shulman HM, Gooley T, Dudley MD et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995; 59: 1015-1022.
50. Myerowitz RL, Pazin GJ, Allen CM. Disseminated candidiasis: changes in incidence, underlying disease, and pathology. Am J Clin Pathol 1977; 68: 29-38.
51. Thaler M, Pastakia B, Shawker T et al. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988; 108: 88-100.
52. Otheo De Tejada E, Maldonado MS, Camarero C, Muñoz A. Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT. Bone Marrow Transplant 1995; 14: 176-177.
53. Tischler HJ, Stoll M, Bettoni C et al. Recombinant tissue plasminogen activator (rtPA) for hepatic veno-occlusive disease after BMT: fatal hemorrhagic complications in two patients. 19th Annual Meeting of the EBMT, 1993, p 78 (abstr. 2608).
54. Martin PJ, Schoch G, Fisher L et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 1464-1472.
55. Martin PJ, Schoch G, Fisher L et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991; 77: 1821-1828.